Dataset for Clinical Analysis: Insulin-like Proteins and Glycemic Impact of Spray-Dried Camel Milk

Published: 23 February 2026| Version 1 | DOI: 10.17632/swndh73grn.1
Contributor:
Adrian Wadowski

Description

This dataset provides supplemental nutritional and clinical markers derived from the research report "Camel Milk and Diabetes: Science-Backed Benefits for Type 1 and Type 2 Patients" (DOI: 10.5281/zenodo.17184240). Data includes: - Comparative concentrations of insulin-like proteins (approx. 52 units/liter) in camel milk versus bovine alternatives. - Synthesis of HbA1c and fasting glucose reduction trends from randomized controlled trials (RCTs). - Technical specifications of low-temperature spray-dried camel milk powder produced under EU standards. Research conducted by the Head of Research & Strategic Partnerships at CamelWay. Full documentation and educational hub available at: https://camelway.eu/pages/camel-milk-and-diabetes-evidence Official Corporate Website: https://camelway.eu/

Files

Steps to reproduce

Data was synthesized through a systematic review of clinical trials indexed in PubMed, BioMed Central, and PMC. Nutritional profiles were verified based on lab analysis of CamelWay™ spray-dried camel milk (Dubai/EU certified facilities).

Categories

Diabetes, Type 1 Diabetes, Diabetes Mellitus, Casomorphin, Camel Milk

Licence